cannabidiol

Key facts

INN

cannabidiol

Brand

EPIDIOLEX

Route

ORAL

Formulation

SOLUTION

Originator

Jazz Pharmaceuticals plc

Related patents

patent

US 12396963

Cannabidiol-type cannabinoid compound

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12383512

Cannabidiol-type cannabinoid compound

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12364670

Cannabidiol-type cannabinoid compound

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12357586

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12263139

Use of cannabidiol in the treatment of tuberous sclerosis complex

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12226373

Treatment of fragile X syndrome with cannabidiol

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12213951

Treatment of autism with cannabidiol

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12186282

Treatment of 22Q11.2 deletion syndrome with cannabidiol

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is cannabidiol?

cannabidiol (EPIDIOLEX), is a pharmaceutical active ingredient, associated with Jazz Pharmaceuticals plc, with approved status in the US.

What is the brand name for cannabidiol?

EPIDIOLEX is a marketed brand name for cannabidiol. Check FDA Drugs@FDA for the current US label holder.